Age-specific variation in aneuploidy incidence among biochemical screening programs

American Journal of Obstetrics and Gynecology

Volumn 179, Issue 4, 1998, Pages 971-973

  Sokol, A I ^a   Kramer, R L ^a   Yaron, Y ^a   O'Brien, J E ^a   Muller, F ^a   Johnson, M P ^a   Evans, M I ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aneuploidy; Biochemical screening; Down syndrome

Indexed keywords

ADOLESCENT; ADULT; ANEUPLOIDY; CONFERENCE PAPER; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MASS SCREENING; MATERNAL AGE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0031791217     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70199-1     Document Type: Conference Paper

References (17)

1. IR Merkatz HM Nitowsky JN Macri WE. Johnson An association between low maternal serum fetoprotein and fetal chromosomal abnormalities Am J Obstet Gynecol 148 1984 886 894
2. HS Cuckle NJ Wald RH. Lindenbaum Maternal serum alpha-fetoprotein measurement: a screening test for Down syndrome Lancet 1 1984 926 929
3. MH Bogart MR Pandian OW. Jones Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities Prenat Diagn 7 1987 623 630
4. JA Canick GJ Knight GE Palomaki JE Haddow HS Cuckle NJ Wald Low second trimester maternal serum unconjugated oestriol in pregnancies with Down’s syndrome Br J Obstet Gynaecol 95 1988 330 333
5. NJ Wald HS Cuckle JW Densem K Nanchahal P Royston T Chard BMJ 297 1988 883 887
6. JE Haddow GE Palomaki GJ Knight GC Cunningham LS Lustig PA. Boyd Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening N Engl J Med 330 1994 1114 1118
7. HS Cuckle NJ Wald SG Thompson Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level Br J Obstet Gynaecol 94d 1987 387 402
8. EB Hook GM. Chambers Estimated rates of Down syndrome in live births by one year maternal age intervals for mothers aged 20-49 in a New York State study: implications of the risk figures for genetic counseling and cost-benefit analysis of prenatal diagnosis programs Birth Defects: Original Article Series XIII 34 1977 123 141
9. MI Evans L Chik JE O’Brien B Chin E Dvorin M Ayoub MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs Am J Obstet Gynecol 172 1995 1138 1147
10. MI Evans L Chik JE O’Brien E Dvorin MP Johnson E Krivchenia Logistic regression generated probability estimates for trisomy 21 outcomes from serum alpha fetoprotein and beta human chorionic gonadotropin: simplification with increased specificity J Matern Fetal Med 5 1996 1 6
11. L Chik K Spencer MP Johnson M Ayoub EL Krivchenia MP Dombrowski Precise gaussian distribution functions of maternal serum α-fetoprotein and free β-subunit of human chorionic gonadotropin for trisomy 21 screening: improved accuracy for patient counseling Am J Obstet Gynecol 177 1997 882 886
12. American College of Obstetricians and Gynecologists Maternal serum screening 1996 The College Washington Educational Bulletin No.: 228
13. HS Cuckle NJ Wald Screening for Down’s syndrome RJ Lilford Prenatal diagnosis and prognosis 1990 Butterworth London 67 92
14. EB Hook DE Mutton R Ide E Alberman M. Bobrow The natural history of Down syndrome conceptuses diagnosed prenatally that are not electively terminated Am J Hum Genet 57 1995 875 881
15. T Huang HC Watt NJ Wald JK Morris D Mutton E Alberman Reliability of statistics on Down’s syndrome notifications J Med Screen 4 1997 95 97
16. CA Hecht EB. Hook Rates of Down syndrome at livebirth by one-year maternal age intervals in studies with apparent close to complete ascertainment in populations of European origin: a proposed revised rate schedule for use in genetic and prenatal screening Am J Med Genet 62 1996 376 385
17. CA Hecht EB. Hook The imprecision in rates of Down syndrome by 1-year maternal age intervals: a critical analysis of rates used in biochemical screening Prenat Diagn 14 1994 729 738